id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2019-N-5900-0028,FDA,FDA-2019-N-5900,Ref 16 - BisawsBiswas&Das2006 celeb expert RE Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Endorser Status and Explicitness of Payment in Directto-Consumer Promotion,Supporting & Related Material,Background Material,2020-12-11T05:00:00Z,2020,12,,,2020-12-11T17:07:12Z,,0,0,0900006484998e6f
FDA-2019-N-5900-0027,FDA,FDA-2019-N-5900,Ref 15 - Till&Busler2000_match up hyp RE Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Endorser Status and Explicitness of Payment in Directto-Consumer Promotion,Supporting & Related Material,Background Material,2020-12-11T05:00:00Z,2020,12,,,2020-12-11T17:07:04Z,,0,0,0900006484998e6e
FDA-2019-N-5900-0019,FDA,FDA-2019-N-5900,Ref 7 - U.S._ Average age of Instagram users _ Statista RE Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Endorser Status and Explicitness of Payment in Directto-Consumer Promotion,Supporting & Related Material,Background Material,2020-12-11T05:00:00Z,2020,12,,,2020-12-11T17:05:45Z,,0,0,0900006484998e66
FDA-2019-N-5900-0024,FDA,FDA-2019-N-5900,Ref 12 -  Brown&Bocarnea2007 RE Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Endorser Status and Explicitness of Payment in Directto-Consumer Promotion,Supporting & Related Material,Background Material,2020-12-11T05:00:00Z,2020,12,,,2020-12-11T17:06:27Z,,0,0,0900006484998e6b
FDA-2019-N-5900-0014,FDA,FDA-2019-N-5900,Ref 1 - LaTour&Smith1986 RE Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Endorser Status and Explicitness of Payment in Directto-Consumer Promotion,Supporting & Related Material,Background Material,2020-12-11T05:00:00Z,2020,12,,,2020-12-11T17:04:57Z,,0,0,0900006484998962
FDA-2019-N-5900-0016,FDA,FDA-2019-N-5900,Ref 3 - Boerman et al 2017 sponsored posts FB RE Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Endorser Status and Explicitness of Payment in Directto-Consumer Promotion,Supporting & Related Material,Background Material,2020-12-11T05:00:00Z,2020,12,,,2020-12-11T17:05:20Z,,0,0,0900006484998964
FDA-2019-N-5900-0017,FDA,FDA-2019-N-5900,Ref 5 - Faul2007_Article_GPower3AFlexibleStatisticalPow RE Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Endorser Status and Explicitness of Payment in Directto-Consumer Promotion,Supporting & Related Material,Background Material,2020-12-11T05:00:00Z,2020,12,,,2020-12-11T17:05:30Z,,0,0,0900006484998e64
FDA-2019-N-5900-0015,FDA,FDA-2019-N-5900,Ref 2 - Bhutada Rollins 2015 RE Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Endorser Status and Explicitness of Payment in Directto-Consumer Promotion,Supporting & Related Material,Background Material,2020-12-11T05:00:00Z,2020,12,,,2020-12-11T17:05:12Z,,0,0,0900006484998963
FDA-2019-N-5900-0022,FDA,FDA-2019-N-5900,Ref10 - Kamins and Gupta.Robins RE Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Endorser Status and Explicitness of Payment in Directto-Consumer Promotion,Supporting & Related Material,Background Material,2020-12-11T05:00:00Z,2020,12,,,2020-12-11T17:06:12Z,,0,0,0900006484998e69
FDA-2019-N-5900-0023,FDA,FDA-2019-N-5900,Ref 11 - PhuaLin&Lim2018 RE Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Endorser Status and Explicitness of Payment in Directto-Consumer Promotion,Supporting & Related Material,Background Material,2020-12-11T05:00:00Z,2020,12,,,2020-12-11T17:06:19Z,,0,0,0900006484998e6a
FDA-2019-N-5900-0021,FDA,FDA-2019-N-5900,Ref 9 - Ohanian1991 intent RE Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Endorser Status and Explicitness of Payment in Directto-Consumer Promotion,Supporting & Related Material,Background Material,2020-12-11T05:00:00Z,2020,12,,,2020-12-11T17:06:02Z,,0,0,0900006484998e68
FDA-2019-N-5900-0026,FDA,FDA-2019-N-5900,Ref 14 - HuhDeLormeReid2004 RE Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Endorser Status and Explicitness of Payment in Directto-Consumer Promotion,Supporting & Related Material,Background Material,2020-12-11T05:00:00Z,2020,12,,,2020-12-11T17:06:57Z,,0,0,0900006484998e6d
FDA-2019-N-5900-0018,FDA,FDA-2019-N-5900,Ref 6. - Woods et al (2017) RE Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Endorser Status and Explicitness of Payment in Directto-Consumer Promotion,Supporting & Related Material,Background Material,2020-12-11T05:00:00Z,2020,12,,,2020-12-11T17:05:38Z,,0,0,0900006484998e65
FDA-2019-N-5900-0020,FDA,FDA-2019-N-5900,Ref 8 - Zaichowsky1994 RE Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Endorser Status and Explicitness of Payment in Directto-Consumer Promotion,Supporting & Related Material,Background Material,2020-12-11T05:00:00Z,2020,12,,,2020-12-11T17:05:52Z,,0,0,0900006484998e67
FDA-2019-N-5900-0025,FDA,FDA-2019-N-5900,Ref 13 - Brown&Matviuk2010 RE Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Endorser Status and Explicitness of Payment in Directto-Consumer Promotion,Supporting & Related Material,Background Material,2020-12-11T05:00:00Z,2020,12,,,2020-12-11T17:06:34Z,,0,0,0900006484998e6c
FDA-2019-N-5900-0029,FDA,FDA-2019-N-5900,Ref 17 - Bocarnea&Brown2007 RE Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Endorser Status and Explicitness of Payment in Directto-Consumer Promotion,Supporting & Related Material,Background Material,2020-12-11T05:00:00Z,2020,12,,,2020-12-11T17:07:19Z,,0,0,0900006484998e70
FDA-2019-N-5900-0012,FDA,FDA-2019-N-5900,Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Endorser Status and Explicitness of Payment in Directto-Consumer Promotion,Notice,30 Day Proposed Information Collection,2020-12-07T05:00:00Z,2020,12,2020-12-07T05:00:00Z,2021-01-07T04:59:59Z,2020-12-08T02:00:52Z,2020-26799,0,0,0900006484989f3f
FDA-2019-N-5900-0009,FDA,FDA-2019-N-5900,"Request for Extension from Academy, Ltd. d/b/a Academy Sports + Outdoors",Other,Request for Extension,2020-04-01T04:00:00Z,2020,4,2020-04-01T04:00:00Z,,2020-04-01T15:00:18Z,,0,0,090000648447893c
FDA-2019-N-5900-0004,FDA,FDA-2019-N-5900,A Study of Expert Endorsement of OTC Pharmaceutical Products LaTour&Smith1986 RE: Agency Information Collection Activities; Proposed Collection; Comment Request; Endorser Status and Explicitness of Payment in Direct-to- Consumer Promotion,Supporting & Related Material,Background Material,2020-01-28T05:00:00Z,2020,1,,,2020-01-28T18:32:19Z,,0,0,09000064842fd532
FDA-2019-N-5900-0002,FDA,FDA-2019-N-5900,"""This Post Is Sponsored” Effects of Sponsorship Disclosure on Persuasion Knowledge and Electronic Word of Mouth in the Context of Facebook RE: Agency Information Collection Activities; Proposed Collection; Comment Request; Endorser Status and Explicitness of Payment in Direct-to- Consumer Promotion",Supporting & Related Material,Background Material,2020-01-28T05:00:00Z,2020,1,,,2020-01-28T18:37:17Z,,0,0,09000064842fd530
FDA-2019-N-5900-0001,FDA,FDA-2019-N-5900,Agency Information Collection Activities; Proposed Collection; Comment Request; Endorser Status and Explicitness of Payment in Direct-to- Consumer Promotion,Notice,60 Day Proposed Information Collection,2020-01-28T05:00:00Z,2020,1,2020-01-28T05:00:00Z,2020-03-31T03:59:59Z,2020-04-02T01:02:51Z,2020-01408,0,0,09000064842faa38
FDA-2019-N-5900-0003,FDA,FDA-2019-N-5900,"Disease-specific direct-to-consumer advertising of pharmaceuticals: An examination of endorser type and gender effects on consumers’ attitudes and behaviors Nilesh S. Bhutada, Ph.D.a, Brent L. Rollins, R.Ph., Ph.D.b,* RE: Agency Information Collection Activities; Proposed Collection; Comment Request; Endorser Status and Explicitness of Payment in Direct-to- Consumer Promotion",Supporting & Related Material,Background Material,2020-01-28T05:00:00Z,2020,1,,,2020-01-28T18:32:11Z,,0,0,09000064842fd531